Clinical Trials · NCT00333151
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 576
- Start date
- May 2006
- Locations
- 89 sites, United States, Canada
- Primary endpoint
- HbA1c